Cargando…

CYP450 Mediates Reactive Oxygen Species Production in a Mouse Model of β-Thalassemia through an Increase in 20-HETE Activity

Oxidative damage by reactive oxygen species (ROS) is one of the main contributors to cell injury and tissue damage in thalassemia patients. Recent studies suggest that ROS generation in non-transfusion-dependent (NTDT) patients occurs as a result of iron overload. Among the different sources of ROS,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bou-Fakhredin, Rayan, Dia, Batoul, Ghadieh, Hilda E., Rivella, Stefano, Cappellini, Maria Domenica, Eid, Assaad A., Taher, Ali T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865490/ https://www.ncbi.nlm.nih.gov/pubmed/33498614 http://dx.doi.org/10.3390/ijms22031106

Ejemplares similares

Redox Balance in β-Thalassemia and Sickle Cell Disease: A Love and Hate Relationship
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2022)

Beta Thalassemia: New Therapeutic Options Beyond Transfusion and Iron Chelation
por: Motta, Irene, et al.
Publicado: (2020)

Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2022)

Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management
por: Sleiman, Joseph, et al.
Publicado: (2018)

Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
por: Bou-Fakhredin, Rayan, et al.
Publicado: (2017)

SGLT2 Inhibitor—Dapagliflozin Attenuates Diabetes-Induced Renal Injury by Regulating Inflammation through a CYP4A/20-HETE Signaling Mechanism
por: Dia, Batoul, et al.
Publicado: (2023)

Deferasirox: Over a Decade of Experience in Thalassemia
por: Moukalled, Nour M., et al.
Publicado: (2018)

20-HETE and EETs in Diabetic Nephropathy: A Novel Mechanistic Pathway
por: Eid, Stephanie, et al.
Publicado: (2013)

Thalassemia in the emergency department: special considerations for a rare disease
por: Saliba, Antoine N., et al.
Publicado: (2020)

EHA Research Roadmap on Hemoglobinopathies and Thalassemia: An Update
por: Iolascon, Achille, et al.
Publicado: (2019)

Novel Approach to Reactive Oxygen Species in Nontransfusion-Dependent Thalassemia
por: Tyan, Paul I., et al.
Publicado: (2014)

Urinary 20-HETE: A prospective Non-Invasive prognostic and diagnostic marker for diabetic kidney disease
por: Houeiss, Pamela, et al.
Publicado: (2022)

Right in time: Mitapivat for the treatment of anemia in α- and β-thalassemia
por: Musallam, Khaled M., et al.
Publicado: (2022)

Conflicting Roles of 20-HETE in Hypertension and Stroke
por: Shekhar, Shashank, et al.
Publicado: (2019)

Coagulopathy in Beta-Thalassemia: Current Understanding and Future Perspectives
por: Cappellini, M. Domenica, et al.
Publicado: (2009)

β-Thalassemia: New Therapeutic Modalities, Genetics, Complications, and Quality of Life
por: Karimi, Mehran, et al.
Publicado: (2012)

Treating iron overload in patients with non-transfusion-dependent thalassemia
por: Taher, Ali T, et al.
Publicado: (2013)

Pseudomonas aeruginosa cytochrome P450 CYP168A1 is a fatty acid hydroxylase that metabolizes arachidonic acid to the vasodilator 19-HETE
por: Tooker, Brian C., et al.
Publicado: (2022)

2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia
por: Farmakis, Dimitrios, et al.
Publicado: (2022)

Effect of Chronically Suppressed Plasma Angiotensin II on Regulation of the CYP4A/20-HETE Pathway in the Dahl Salt-Sensitive Rat
por: Lukaszewicz, Kathleen, et al.
Publicado: (2023)

Theoretical model for neurovascular coupling via interactions of NO, EET, and 20-HETE
por: Kang, Hyuk, et al.
Publicado: (2013)

20-HETE Enzymes and Receptors in the Neurovascular Unit: Implications in Cerebrovascular Disease
por: Gonzalez-Fernandez, Ezekiel, et al.
Publicado: (2020)

Luspatercept for transfusion-dependent β-thalassemia: time to get real
por: Musallam, Khaled M., et al.
Publicado: (2023)

Deep venous thrombosis and pulmonary embolism after COVID-19 mRNA vaccination
por: Atoui, Ali, et al.
Publicado: (2022)

Manifestation of paroxysmal nocturnal hemoglobinuria after COVID-19 mRNA vaccination
por: Jarrah, Kawthar, et al.
Publicado: (2022)

Targeting 20-HETE producing enzymes in cancer – rationale, pharmacology, and clinical potential
por: Alexanian, Anna, et al.
Publicado: (2013)

Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
por: Taher, Ali T, et al.
Publicado: (2016)

Gene Therapy in Thalassemia and Hemoglobinopathies
por: Breda, Laura, et al.
Publicado: (2009)

20-HETE Mediates Ozone-Induced, Neutrophil-Independent Airway Hyper-Responsiveness in Mice
por: Cooper, Philip R., et al.
Publicado: (2010)

20-HETE Participates in Intracerebral Hemorrhage-Induced Acute Injury by Promoting Cell Ferroptosis
por: Han, Ranran, et al.
Publicado: (2021)

High Salt Intake Increases Blood Pressure in Normal Rats: Putative Role of 20-HETE and No Evidence on Changes in Renal Vascular Reactivity
por: Walkowska, A., et al.
Publicado: (2015)

Untreated Anemia in Nontransfusion-dependent β-thalassemia: Time to Sound the Alarm
por: Musallam, Khaled M., et al.
Publicado: (2022)

Profile of Luspatercept in the Treatment of Anemia in Adults with Non-Transfusion-Dependent β-Thalassemia (NTDT): Design, Development and Potential Place in Therapy
por: Musallam, Khaled M, et al.
Publicado: (2023)

20-HETE promotes glucose-stimulated insulin secretion in an autocrine manner through FFAR1
por: Tunaru, Sorin, et al.
Publicado: (2018)

Reno-Protective Effect of GLP-1 Receptor Agonists in Type1 Diabetes: Dual Action on TRPC6 and NADPH Oxidases
por: Youssef, Natalie, et al.
Publicado: (2021)

20-Hydroxyeicosatetraenoic Acid (20-HETE) Modulates Canonical Transient Receptor Potential-6 (TRPC6) Channels in Podocytes
por: Roshanravan, Hila, et al.
Publicado: (2016)

Immunomodulatory Approaches in Diabetes-Induced Cardiorenal Syndromes
por: Ammar, Lama A., et al.
Publicado: (2021)

Afferent arteriolar responses to β,γ-methylene ATP and 20-HETE are not blocked by ENaC inhibition
por: Nagasawa, Tasuku, et al.
Publicado: (2013)

Androgen-sensitive hypertension associated with soluble guanylate cyclase alpha1 deficiency is mediated by 20-HETE
por: Vandenwijngaert, Sara, et al.
Publicado: (2015)

Epoxyeicosatrienoic Acid Analog and 20-HETE Antagonist Combination Prevent Hypertension Development in Spontaneously Hypertensive Rats
por: Baranowska, Iwona, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2bi6hi70djgstnhdjqeu42o2hm